Documents & Studies

Here's a sampling of documents and studies that tell a very different story from what you will hear in the media.
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

Many in the press and Dr. Fauci himself have been downplaying or dismissing the role of natural immunity. This Israeli study supports what the so-called conspiracy theory doctors have been saying all along. Natural immunity is durable and long-lasting. The question is why Dr. Fauci is asking people to suspend common sense.

SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant for symptomatic disease as well. When allowing the infection to occur at any time before vaccination (from March 2020 to February 2021), evidence of waning natural immunity was demonstrated, though SARS-CoV-2 naïve vaccinees had a 5.96-fold (95% CI, 4.85 to 7.33) increased risk for breakthrough infection and a 7.13-fold (95% CI, 5.51 to 9.21) increased risk for symptomatic disease. SARS-CoV-2-naïve vaccinees were also at a greater risk for COVID-19-related-hospitalizations compared to those that were previously infected.

This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant

Considerations in boosting COVID-19 vaccine immune responses

FDA's long-serving Marion Gruber and Phil Krause felt it necessary to resign their positions while under pressure to greenlight a COVID booster shot. Their reasoning was published in the Lancet. The voices of reason are either getting fired or quitting in protest, leaving only the Peoples Temple true believers in charge. God help us.

Although the benefits of primary COVID-19 vaccination clearly outweigh the risks, there could be risks if boosters are widely introduced too soon, or too frequently, especially with vaccines that can have immune-mediated side-effects (such as myocarditis, which is more common after the second dose of some mRNA vaccines,3 or Guillain-Barre syndrome, which has been associated with adenovirus-vectored COVID-19 vaccines4 ).

Even without any changes in vaccine efficacy, increasing success in delivering vaccines to large populations will inevitably lead to increasing numbers of breakthrough cases, especially if vaccination leads to behavioural changes in vaccinees.

If new variants that can escape the current vaccines are going to evolve, they are most likely to do so from strains that had already become widely prevalent. The effectiveness of boosting against the main variants now circulating and against even newer variants could be greater and longer lived if the booster vaccine antigen is devised to match the main circulating variants.

WHO has called for a moratorium on boosting until the benefits of primary vaccination have been made available to more people around the world.18 This is a compelling issue, particularly as the currently available evidence does not show the need for widespread use of booster vaccination in populations that have received an effective primary vaccination regimen.

DARPA - PREEMPT (HR001118S0017)

Zoologist Peter Daszak of EcoHealth Alliance seems to be neck-deep in doing and attempting to do what Dr. Fauci claims EcoHealth is not doing. This proposal to DARPA was rejected because of its dangerous nature and was deemed potentially GoF (Gain of Function) research.

It is becoming increasingly difficult to imagine that the EcoHealth Alliance was not responsible for creating SARS-CoV-2.

“Given the team's approach does potentially involve GoF/DURC research (they aim to synthesize spike glycoproteins that may bind to human cell receptors and insert them into SARSr-CoV backbones to assess capacity to cause SARS-like disease), if selected for funding an appropriate DURC risk mitigation plan should be incorporated into contracting language that includes a responsible communications plan”

Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy and Oncolytic Products

If you thought shedding was a conspiracy theory, think again. This document from the FDA outlines design criteria for shedding studies. Shedding is the transmission of treatment from a treated individual to an untreated individual.

Shedding studies should be conducted for each VBGT or oncolytic product to provide information about the likelihood of transmission to untreated individuals because historical data alone may not be predictive of the shedding profile. Shedding data can be used to evaluate measures to prevent transmission.

EcoHealth Alliance - Understanding-Risk-Bat-Coronavirus-Emergence-Grant-Notice

This copy of the research grant to the EcoHealth Alliance ties it to the possible lab creation of the SARS CoV 2 virus. It looks like Dr. Fauci lied about funding gain of function research at the Wuhan Institute of Virology. Call it what you want, A rose by any other name would smell as sweet.

The focus of this project is to understand the risk of coronavirus spillover from bats to people in China, using ecological analyses, fieldwork, receptor binding assays, and modeling approaches. I have worked in lab-based virology for 23 years, specializing in SARS-CoV and SARS-like CoVs since 2002. This includes the discovery of a wide-array of SARS-like coronaviruses in mainland China, including two isolates able to bind to the ACE2 receptor. My lab has established several bat primary cell lines and immortalized cell lines, capacity for pseudovirus generation and SARS-specific binding assays and we have expertise in every laboratory technique in this proposal. I have collaborated with the Pl for over 10 years, and have spent time in laboratories in the USA and Europe. My lab will be responsible for diagnosis, genomics and isolation of coronavirus from wild and domestic animals in Southern China and for analyzing their receptor binding domains.

England Public Health Technical briefing 23 9-17-21

This technical briefing shows (on page 20) that 722 unvaccinated and 1622 fully vaccinated people died of the Delta variant from Feb 1st, 2021, to Sept 12th, 2021 in England. It looks like not only do vaccinated people spread the virus as readily as the unvaccinated, but it does also not even protect them from death as was the claim. Am I missing something? And with results like these and unknown long-term outcomes, can someone please explain to me why anyone mandates this vaccine?

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

Yet another study supports the safety and effectiveness of ivermectin. Since it is off-patent, I don’t expect this drug to be FDA approve for the early treatment of SARS-CoV-2 anytime soon, however. Apparently, it is all about making money, not saving lives. I don’t know what other explanation there could be.

The study depicts that a low dose of ivermectin (5 micromolar) can induce 93% reduction in viral RNA from released virion and 99.8% reduction in cell-associated/unreleased virion after 24 h of incubation. Interestingly, reduction of viral RNA was found to be increased up to 5000-times after 48 h of treatment

FDA Safety Surveillance of COVID-19 Vaccines

This FDA draft PowerPoint of possible adverse events was accidentally leaked in a video conference. It might help explain why Marion Gruber, director of the Office of Vaccines Research & Review (OVRR), and Phil Krause, OVRR deputy director left the FDA when pressured to speed up the approval process.

Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis

If SARS-CoV-2 was created in a lab, which is increasingly looking like it is the case, this paper might well describe how an existing virus was manipulated to develop SARS-CoV-2.

Sequence analysis indicates that the novel coronavirus (CoV) has an insertion of a furin cleavage site (PRRAR) in its spike protein. Absent in other group 2B CoVs, the insertion may be a key factor in the replication and virulence of SARS-CoV-2.

John Hopkins Bloomberg School of Public Health - SPARS Pandemic Scenario

The SPARS Pandemic 2025 – 2028 was written in October of 2017. It is a bit astonishing how predictive this document as been. It helps explain why some "conspiracy" oriented individuals have labeled it a plandemic.

The Center’s SPARS Pandemic exercise narrative comprises a futuristic scenario that illustrates communication dilemmas concerning medical countermeasures (MCMs) that could plausibly emerge in the not-so-distant future.

Lab-Made Coronavirus Triggers Debate

This article appeared in TheScientist on Nov 16, 2015. Lab-Made Coronavirus is in the article's title, yet on March 11, 2020, the publication felt it necessary to tag the article with this.

Update (March 11, 2020): On social media and news outlets, a theory has circulated that the Coronavirus at the root of the COVID-19 outbreak originated in a research lab. Scientists say there is no evidence that the SARS-CoV-2 virus escaped from a lab.

The pandemic had just started, no serious investigation had been made, and yet these "no evidence the virus escaped from a lob' warning labels began appearing everywhere. It reminds me of a Simpsons episode where Bart says, "I didn't do it, nobody saw me."

The results demonstrate the ability of the SHC014 surface protein to bind and infect human cells, validating concerns that this virus—or other coronaviruses found in bat species—may be capable of making the leap to people without first evolving in an intermediate host, Nature reported. They also reignite a debate about whether that information justifies the risk of such work, known as gain-of-function research. “If the [new] virus escaped, nobody could predict the trajectory,” Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris, told Nature. The results demonstrate the ability of the SHC014 surface protein to bind and infect human cells, validating concerns that this virus—or other coronaviruses found in bat species—may be capable of making the leap to people without first evolving in an intermediate host, Nature reported. They also reignite a debate about whether that information justifies the risk of such work, known as gain-of-function research. “If the [new] virus escaped, nobody could predict the trajectory,” Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris, told Nature.

National Childhood Vaccine Injury Act - 1986

Provides that no vaccine manufacturer shall be liable in a civil action for damages arising from a vaccine-related injury or death. Pharmaceutical companies can only be sued for a vaccine injury if the ‘side effect’ is not listed on the vaccine insert. Before receiving a vaccine, read the insert, so you are aware of the risks. It is worth noting that emergency use vaccines are not required to list side effects.

The National Childhood Vaccine Injury Act (NCVIA) of 1986 (42 U.S.C. §§ 300aa-1 to 300aa-34) was signed into law by United States President Ronald Reagan as part of a larger health bill on November 14, 1986. NCVIA's purpose was to eliminate the potential financial liability of vaccine manufacturers due to vaccine injury claims[1] to ensure a stable market supply of vaccines, and to provide cost-effective arbitration for vaccine injury claims.

Phylodynamic Analysis | 176 genomes | 6 Mar 2020

It is worth noting that the author presupposes a zoonotic origin of covid-19; the author states that all variations are human to human in nature, and there is no evidence of new infections coming from an animal reservoir at it origin. In my view, this very lack of evidence for a zoonotic origin or reservoir bolsters the lab-created argument.

Although this is increasingly obvious from the reports of spread and numbers of confirmed cases and definitive evidence of human to human transmission, the genome sequence data shows no evidence that any non-human animal reservoir has been involved in generating new cases after the initial zoonotic event. If cases in January had been the result of new zoonotic jumps from a reservoir, we would expect those genomes to be more divergent and lie outside the observed diversity to that point.

Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains

At the beginning of the COVID-19 pandemic, I suggested that the best thing to do was follow the Swede's initial strategy of just letting the virus pass through the population. Also, using early treatment methods as recommended by Dr. Peter McCullough made sense as well.

This study supports my long-held belief that because of the nature of Corona Viruses, the long-term effectiveness of a vaccine would be futile and probably only make things worse.

My reading of this study is that we have created a worst-case scenario with both a high vaccination rate and a high transmission rate. It makes you wonder if our health officials at the NIH and CDC are just stupid or have a nefarious agenda. I'm currently giving them the benefit of the doubt and assuming that they are just that stupid.

If I am the stupid one, please reach out and educate me. I could be wrong.

Our model suggests three specific risk factors that favour the emergence and establishment of a vaccine-resistant strain that are intuitively obvious: high probability of initial emergence of the resistant strain, high number of infected individuals54 and low rate of vaccination55. By contrast, a counterintuitive result of our analysis is that the highest risk of resistant strain establishment occurs when a large fraction of the population has already been vaccinated but the transmission is not controlled. Similar conclusions have been reached in a SIR model of the ongoing pandemic56 and a model of pathogen escape from host immunity57. Furthermore, empirical data consistent with this result has been reported for influenza58. Indeed, it seems likely that when a large fraction of the population is vaccinated, especially the high-risk fraction of the population (aged individuals and those with specific underlying conditions) policy makers and individuals will be driven to return to pre-pandemic guidelines59 and behaviours conducive to a high rate of virus transmission60,61. However, the establishment of a resistant strain at that time may lead to serial rounds of resistant strain evolution with vaccine development playing catch up in the evolutionary arms race against novel strains.

Red Cross - Convalescent plasma collection program

Answers to Common Questions About COVID-19 Vaccines and Blood, Platelet or Plasma Donation Eligibility. It is interesting to note that antibodies from covid infected individuals are different from individuals who have receive the vaccine.

Antibodies that an individual produces when they’ve been exposed to the virus are slightly different from the antibodies that an individual produces when they’ve been vaccinated. When an individual has been infected with a virus, they produce antibodies to multiple regions of a virus, including the nucleocapsid protein. An individual who has received a COVID-19 vaccine will produce antibodies to the spike protein of the virus, but not the nucleocapsid protein, which will only occur in the event of a COVID-19 infectio

SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048) 2.6.4 Summary of pharmacokinetic study

The regulator did not require Pfizer to do a biodistribution study of the vaccine lipid nanoparticles because it was assumed that lipid nanoparticles (LNP) from the injection would remain in the deltoid muscle region.

This leaked document from Japan marked ‘PFIZER CONFIDENTIAL’ shows that Pfizer’s internal investigation into the matter tells a very different story. According to this document, lipid nanoparticles (LNP) are widely distributed through the body. Sounds ‘problematic’ to me. More to come.

Self-disseminating vaccines to suppress zoonoses

Self-disseminating sterilizing vaccines for small mammal control, what could go wrong. How long till a human mammal sterilizing vaccine is created? Or how do we know one has not already been made and is this what Bill Gates was talking about when he said the next pandemic would be much worse?

Self-disseminating vaccines have their roots in the Australian effort to create sterilizing vaccines for small mammal control15,16, and have also been developed and tested experimentally as a tool for vaccinating rabbits against myxomatosis and rabbit haemorrhagic fever17,18,19. Their obvious advantage, of course, is that for each animal you vaccinate directly, additional animals are vaccinated for ‘free’ either through behavioural transmission of a conventional vaccine or through the contagious spread of a transmissible vaccine.

The Fauci/COVID-19 Dossier

If you are prone to thinking that Dr. Fauci has committed crimes against humanity, then this document written by Dr. David E. Martin is for you. If you believe Dr. Fauci is a saint who is simply trying to save the world, then look away, look away, look away, Dixie Land.

The Nuremberg Code (1949)

When the jack-booted thugs come pounding on your door demanding you take a vaccine and you don’t want to, then I would pull the Nuremberg Code. Read and print the code and have it ready if it comes to that.

Personally, I would have taken the vaccine if the following criteria had been met:

  1. A relative had not died after taking the vaccine.
  2. The vaccine prevented infection and its spread, as was initially claimed.
  3. The vaccine had gone through normal animal trials.
  4. The vaccine had gone through actual phase III trials which generally take 2 – 4 years.
  5. The death rate from COVID-19 was much higher for healthy people.
  6. Pfizer’s trial group was larger than 329, mostly young, healthy people.
  7. Two top-ranking members of the FDA had not quit in protest of booster shots.
  8. The head of the CDC did not ignore her advisory committee’s recommendation regarding booster shots.
  9. The whole thing did not appear to be a money and or power grab.
  10. Klaus Swab and his World Economic Form were not using the pandemic to implement its Great Reset plans.
  11. The VAERS reporting system had not gone through the roof.
  12. The CDC did not manipulate the reporting of COVID-19 cases by adjusting the PCR test sensitivity.
  13. The pandemic had not been used as an economic weapon.
  14. Forced vaccination with an experimental drug were not a violation of the Nuremberg Code

It would never occur to me to make a criteria list before getting a vaccination in normal times. However, since these are not normal times, I have no plan to get the vaccine. Besides, I already had COVID-19, and natural immunity is vastly better than vaccine induce immunity studies show. If you have come to a similar conclusion and feel alone, remember that PHDs are among the most vaccine-hesitant group, and there is a good reason for it.

Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections

Yes, I am not a virologist, but after coming across this study, I could not help but wonder if repeated COVID-19 booster shots might lead to immune exhaustion. Could the immune system come to view booster shots as a chronic infection and react accordingly? And again, this may be wild speculation on my part, but if someone can tell me why repeated booster shots should not raise red flags, let me know. The problem is, I am not convinced virologists know the answer to the question.

At the very least, it would be nice to have some long-term data before forcing booster shots on the entire population. Am I an irrational nut job for asking such a question? Let me know.

Vaccine-induced pathology can occur for many reasons. For instance, the recent adenovirus 5-based vaccination against human immunodeficiency virus (HIV) led to an increased probability of infection following exposure (18). Alternatively, the severity of infection might increase, as seen with respiratory syncytial virus (RSV) following early attempts at immunization (10, 13, 14) and as potentially occurs with dengue virus, with which previous infection with one serotype may result in more severe pathology following challenge with heterologous serotypes (11, 19).

Viral and host factors related to the clinical outcome of COVID-19

It looks like Lymphocytopenia is a significant risk factor in developing critical COVID-19, according to this study. Add that to age and obesity. Lymphocytes are a type of white blood cell in the immune system, and Lymphocytopenia is a condition of having abnormally low levels of lymphocytes.

So does it make sense to have a blood test done to see if you have an underlining condition that may be treatable that would help you fight off SARS-CoV-2 more effectively if you encounter it? My laymen’s brain says yeah, it probably would make sense if you worried about it. It seems to me, having a baseline to measure against is a good idea anyway.

A recent analysis of 1,099 cases of COVID-19 in China found lymphocytopenia to be one of the most common features in laboratory tests5. Here, we have confirmed this observation and further shown that CD3+ T cells were the major cell type that was suppressed in infected patients, whereas CD19+ B cells and CD16+CD56+ NK cells exhibited less suppression. Indeed, lymphopenia and, in particular, reduced CD4+/CD8+ cell counts, are also a major manifestation of SARS-CoV infection12.

Waning Effect of COVID-19 Vaccines in 5.6M U.S. Study Cohort

The DOD (Department of Defense) has tracked the vaccine's effectiveness using medicare data and has produced some interesting data. 80% of people >= 65 have been fully vaccinated, yet the vaccinated represent 71% of the Delta variant cases and 60% of the hospitalizations.

If that news were not bad enough, it was also found that whatever effectiveness the vaccine(s) do have wanes over time, and we are not talking about years; we are talking about months.

According to the provided risk model, people at the lowest risk of developing COVID-19 are (drum roll), who have already had COVID-19 and have achieved natural immunity.

It appears that nearly everyone will be exposed to SARS-CoV-2 at some point and vaccinated or not; it will be natural immunity that saves the day. Some of us are not surprised and have been saying that all along. But does Dr. Fauci or the CDC say anything about bolstering natural immunity? Nope, and I sure would like to know why. Let me know what your theories are.

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

In a nutshell, the durability of the vaccine is the lowest among the two groups that need vaccine protection the most, the old and the immune-compromised. As a result, these two groups will need booster shots and probably often to reduce breakthrough infections. Those who have the most durable, long-lasting protection already had COVID-19—Gee, big surprise there.

What I am getting out of this is the best protection against COVID-19 is to have already had COVID-19 unless you belong to an at-risk population, in which case you may not survive COVID-19 and will need booster shots for the rest of your life or until a better treatment comes along.

So why are young, healthy people getting the vaccine again?

Six months after receipt of the second dose of the BNT162b2 vaccine, humoral response was substantially decreased, especially among men, among persons 65 years of age or older, and among persons with immunosuppression.

The level of IgG antibodies decreased at a consistent rate, whereas the neutralizing antibody level decreased rapidly for the first 3 months with a relatively slow decrease thereafter.

We recently reported that breakthrough infection in BNT162b2-vaccinated persons was correlated with neutralizing antibody titers.

Several studies on the durability of humoral response in persons who have recovered from SARS-CoV-2 infection showed that both IgG and neutralizing antibody levels decrease only modestly at 8 to 10 months after the infection.

Why are we vaccinating children against COVID-19?

This must-read Toxicology Report highlights 16 adverse effects from the SARS-CoV-2 vaccines and how adverse effects, including deaths, are underreported in VAERS. It also describes how the CDC adjusted sensitivity of the PCR test was upped during the ramp-up phase (resulting in 50% false positives to make the pandemic look worse than it was) of the pandemic but then turned down during the vaccination phase (to hide breakout infections from the vaccines).

Section 3 gives a good summary of the 16 identified adverse effects. I believe number 4 perfectly describes what happened to my relative that caused her death, and it perfectly describes what Dr. Charles Hoffe said was happening to his patients.

It is hard to read this study and understand why they CDC and FDA want to vaccinate children, given the long-term risks and the lack of long-term data. I can think of only three possibilities.

  1. Profit.
  2. Groupthink on a mass scale.
  3. Intentional depopulation.
Overall Conclusions - Excerpt:
The people with myriad comorbidities in the age range where most deaths with COVID-19 occurred were in very poor health. Their deaths did not seem to increase all-cause mortality as shown in several studies. If they hadn't died with COVID-19, they probably would have died from the flu or many of the other comorbidities they had. We can't say for sure that many/most died from COVID-19 because of: 1) how the PCR tests were manipulated to give copious false positives and 2) how deaths were arbitrarily attributed to COVID-19 in the presence of myriad comorbidities.

In other words, the spike protein and the surrounding LNP are toxins with the potential to cause myriad short-, mid-, and long-term adverse health effects even in the absence of other contributing factors! Where and when these effects occur will depend on the biodistribution of the injected material. Pfizer’s own biodistribution studies have shown the injected material can be found in myriad critical organs throughout the body, leading to the possibility of multi-organ failure. And these studies were from a single injection. Multiple injections and booster shots may have cumulative effects on organ distributions of inoculant!

20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment

Yet another study supporting early treatment of COVID-19.

Excerpt - Materials
The core supplementation formulations included zinc; zinc ionophores (quina plant bark extract and quercetin); vitamins C, D3 and E; and l-lysine. Sourcing for these components was, except as noted below, from a range of well-known manufacturers of name brand supplements.

Excerpt - Conclusion
Offering a low cost, readily implemented anti-viral approach, the study regimen may serve, at the least, as a stopgap modality and, perhaps, as a useful tool in combatting the pandemic.